Association between use of sodium-glucose cotransporter 2 inhibitors, glucagon-like peptide 1 agonists, and dipeptidyl peptidase 4 inhibitors with all-cause mortality …
Importance The comparative clinical efficacy of sodium-glucose cotransporter 2 (SGLT-2)
inhibitors, glucagon-like peptide 1 (GLP-1) agonists, and dipeptidyl peptidase 4 (DPP-4) …
inhibitors, glucagon-like peptide 1 (GLP-1) agonists, and dipeptidyl peptidase 4 (DPP-4) …
Association of aspirin use for primary prevention with cardiovascular events and bleeding events: a systematic review and meta-analysis
SL Zheng, AJ Roddick - Jama, 2019 - jamanetwork.com
… Author Contributions: Dr Zheng and Mr Roddick had full access to all of the data in the study
… Dr Zheng and Mr Roddick conducted and are responsible for the data analysis. Dr Zheng …
… Dr Zheng and Mr Roddick conducted and are responsible for the data analysis. Dr Zheng …
Implantable cardioverter defibrillators for primary prevention of death in left ventricular dysfunction with and without ischaemic heart disease: a meta-analysis of 8567 …
Aims Primary prevention implantable cardioverter defibrillators (ICDs) are established therapy
for reducing mortality in patients with left ventricular systolic dysfunction and ischaemic …
for reducing mortality in patients with left ventricular systolic dysfunction and ischaemic …
Phenotypic expression and outcomes in individuals with rare genetic variants of hypertrophic cardiomyopathy
Background Hypertrophic cardiomyopathy (HCM) is caused by rare variants in sarcomere-encoding
genes, but little is known about the clinical significance of these variants in the …
genes, but little is known about the clinical significance of these variants in the …
Correspondence on “ACMG SF v3. 0 list for reporting of secondary findings in clinical exome and genome sequencing: a policy statement of the American College of …
We were interested to read the recent update on recommendations for reporting of secondary
findings in clinical sequencing 1 and the accompanying updated list of genes in which …
findings in clinical sequencing 1 and the accompanying updated list of genes in which …
Genotype-Phenotype Taxonomy of Hypertrophic Cardiomyopathy
…, PR Schiratti, A Clement, SL Zheng… - Circulation: Genomic …, 2023 - Am Heart Assoc
BACKGROUND: Hypertrophic cardiomyopathy (HCM) is an important cause of sudden cardiac
death associated with heterogeneous phenotypes, but there is no systematic framework …
death associated with heterogeneous phenotypes, but there is no systematic framework …
Evaluation of polygenic score for hypertrophic cardiomyopathy in the general population and across clinical settings
Hypertrophic cardiomyopathy (HCM) is an important cause of morbidity and mortality, with
rare pathogenic variants found in about a third of cases (sarcomere-positive). Large-scale …
rare pathogenic variants found in about a third of cases (sarcomere-positive). Large-scale …
Intrahepatic bile duct mixed adenoneuroendocrine carcinoma: a case report and review of the literature
Background Mixed adeno-neuroendocrine carcinoma (MANEC) of the biliary tract is rare
with only a few reported cases. Consequently, knowledge about their pathogenesis, …
with only a few reported cases. Consequently, knowledge about their pathogenesis, …
Discontinuation and non-publication of clinical trials in cardiovascular medicine
Background Appropriate dissemination of clinical data is crucial for minimising bias. Despite
this, high rates of study discontinuation and non-publication have been reported among …
this, high rates of study discontinuation and non-publication have been reported among …
Environmental and genetic predictors of human cardiovascular ageing
Cardiovascular ageing is a process that begins early in life and leads to a progressive change
in structure and decline in function due to accumulated damage across diverse cell types, …
in structure and decline in function due to accumulated damage across diverse cell types, …
